Clinical And Translational Allergy impact factor, indexing, ranking (2024)


clinical

Aim and Scope

The Clinical And Translational Allergy is a research journal that publishes research related to Immunology and Microbiology; Medicine. This journal is published by the John Wiley & Sons Inc.. The ISSN of this journal is 20457022. Based on the Scopus data, the SCImago Journal Rank (SJR) of clinical and translational allergy is 1.018.

Also, please check the following important details about clinical and translational allergy: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Clinical And Translational Allergy Ranking

Impact Factor: 5.657
Total Citations: 1836
SJR (SCImago Journal Rank): 1.018
Quartile: Q1

The Impact Factor of Clinical And Translational Allergy is 5.657.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: Clinical and Translational Allergy
Publisher: John Wiley & Sons Inc.
ISSN: 20457022
Type: journal
Journal Scope: Immunology and Microbiology; Medicine
Country: United Kingdom
H-Index: 47
SJR: 1.018
Quartile: Pulmonary and Respiratory Medicine (Q1); Immunology (Q2); Immunology and Allergy (Q2)

clinical and translational allergy Indexing

The clinical and translational allergy is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Clinical And Translational Allergy Impact Factor 2024

The latest impact factor of clinical and translational allergy is 5.657.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Clinical And Translational Allergy Quartile

The latest Quartile of clinical and translational allergy is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Publication fee

According to journal website, the publication fee of clinical and translational allergy is around 3190 USD; 2530 GBP; 2920 EUR.

The clinical and translational allergy has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Clinical And Translational Allergy?

If your research is related to Immunology and Microbiology; Medicine, then visit the official website of clinical and translational allergy and send your manuscript.

Tips for publishing in Clinical And Translational Allergy:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the clinical and translational allergy publishes research articles in 11 weeks on an average.


Final Summary

  • The impact factor of clinical and translational allergy is 5.657.
  • The clinical and translational allergy is a reputed research journal.
  • It is published by John Wiley & Sons Inc..
  • The journal is indexed in UGC CARE, Scopus, SCIE, DOAJ, PubMed.
  • It is an open access journal.
  • The (SJR) SCImago Journal Rank is 1.018.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 11 weeks.
  • The Publication fee (APC) clinical and translational allergy 3190 USD; 2530 GBP; 2920 EUR.

Sources: https://onlinelibrary.wiley.com/journal/20457022







SIMILIAR JOURNALS


JOURNAL OF ANTIBIOTICS

ISSN: 0021-8820
Publisher: SPRINGERNATURE

INNATE IMMUNITY

ISSN: 1753-4259
Publisher: SAGE PUBLICATIONS LTD

INDIAN JOURNAL OF MEDICAL RESEARCH

ISSN: 0971-5916
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

ISSN: 1217-8950
Publisher: AKADEMIAI KIADO ZRT

APMIS

ISSN: 0903-4641
Publisher: WILEY

CLINICAL INFECTIOUS DISEASES

ISSN: 1058-4838
Publisher: OXFORD UNIV PRESS INC

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

ISSN: 0147-9571
Publisher: ELSEVIER SCI LTD

EMERGING MICROBES & INFECTIONS

ISSN:
Publisher: TAYLOR & FRANCIS LTD

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY

ISSN: 2235-2988
Publisher: FRONTIERS MEDIA SA

HUMAN VACCINES & IMMUNOTHERAPEUTICS

ISSN: 2164-5515
Publisher: TAYLOR & FRANCIS INC

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.